About Chemed Corporation
https://www.chemed.comChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter.
CEO
Kevin J. McNamara
Compensation Summary
(Year 2023)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-05-12 | Forward | 2:1 |
| 1981-11-12 | Forward | 2:1 |
ETFs Holding This Stock
JMST
Weight:0.47%
Shares:29.86M
VTS.AX
Weight:0.01%
Shares:458.26K
XMC.TO
Weight:0.19%
Shares:452.49K
Summary
Showing Top 3 of 256
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
METATRON CAPITAL SICAV PLC
Shares:15.4M
Value:$6.96B
VANGUARD GROUP INC
Shares:1.54M
Value:$695.24M
BLACKROCK INC.
Shares:1.44M
Value:$650.87M
Summary
Showing Top 3 of 684
About Chemed Corporation
https://www.chemed.comChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $624.9M ▲ | $105.78M ▼ | $64.24M ▲ | 10.28% ▲ | $4.46 ▲ | $101.78M ▲ |
| Q2-2025 | $618.8M ▼ | $116.61M ▼ | $52.49M ▼ | 8.48% ▼ | $3.6 ▼ | $87.82M ▼ |
| Q1-2025 | $646.94M ▲ | $121.66M ▲ | $71.76M ▼ | 11.09% ▼ | $4.91 ▼ | $112.02M ▼ |
| Q4-2024 | $639.99M ▲ | $120.24M ▲ | $90.32M ▲ | 14.11% ▲ | $6.08 ▲ | $136.45M ▲ |
| Q3-2024 | $606.18M | $117.84M | $75.78M | 12.5% | $5.04 | $117.15M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $129.75M ▼ | $1.62B ▼ | $546.94M ▲ | $1.08B ▼ |
| Q2-2025 | $249.9M ▲ | $1.72B ▼ | $519.36M ▼ | $1.2B ▲ |
| Q1-2025 | $173.88M ▼ | $1.73B ▲ | $544.75M ▼ | $1.18B ▲ |
| Q4-2024 | $178.35M ▼ | $1.67B ▼ | $549.58M ▲ | $1.12B ▼ |
| Q3-2024 | $238.45M | $1.77B | $533.68M | $1.24B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $64.24M ▲ | $83.39M ▼ | $-14.23M ▲ | $-189.31M ▼ | $-120.15M ▼ | $66.03M ▼ |
| Q2-2025 | $52.49M ▼ | $138.61M ▲ | $-15.48M ▼ | $-47.1M ▼ | $76.02M ▲ | $122.8M ▲ |
| Q1-2025 | $71.76M ▼ | $32.74M ▼ | $-13.67M ▼ | $-23.54M ▲ | $-4.47M ▲ | $19.46M ▼ |
| Q4-2024 | $90.32M ▲ | $164.91M ▲ | $-12.52M ▲ | $-212.49M ▼ | $-60.1M ▼ | $152.15M ▲ |
| Q3-2024 | $75.78M | $90.52M | $-18.52M | $-56.45M | $15.55M | $76.97M |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Segment Roto Rooter | $0 ▲ | $230.00M ▲ | $250.00M ▲ | $230.00M ▼ |
 Segment Vitas | $0 ▲ | $420.00M ▲ | $420.00M ▲ | $420.00M ▲ |
 All Other Revenue Self Pay Respite Care Ect | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Care Services Total | $420.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Continuous Care | $30.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Inpatient Care | $30.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Routine Home Care | $360.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
CEO
Kevin J. McNamara
Compensation Summary
(Year 2023)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-05-12 | Forward | 2:1 |
| 1981-11-12 | Forward | 2:1 |
ETFs Holding This Stock
JMST
Weight:0.47%
Shares:29.86M
VTS.AX
Weight:0.01%
Shares:458.26K
XMC.TO
Weight:0.19%
Shares:452.49K
Summary
Showing Top 3 of 256
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
METATRON CAPITAL SICAV PLC
Shares:15.4M
Value:$6.96B
VANGUARD GROUP INC
Shares:1.54M
Value:$695.24M
BLACKROCK INC.
Shares:1.44M
Value:$650.87M
Summary
Showing Top 3 of 684